KHRNF (KHRNF) Stock Price & Analysis
KHRNF (KHRNF) rose 0.00% to USD 0 as of June 10, 2026 at 05:11 UTC, according to Nexqual real-time market data.
KHRNF last closed at USD 0; the session ranged USD 0–0 on volume of 15,039 shares. Market capitalization is $2,324, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 05:11 UTC.
Key Statistics (as of June 10, 2026 at 05:11 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 15,039 shares |
| Market Cap | $2,324 |
| Exchange | PNK |
Technical Analysis (KHRNF)
Nexqual's technical model rates KHRNF "SELL" based on 0 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 05:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (KHRNF)
Wall Street analysts rate KHRNF "None", per Nexqual as of June 10, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (KHRNF)
Source: Nexqual, June 10, 2026 at 05:11 UTC.
Financials & Fundamentals (KHRNF)
| Total Revenue | $16.14M |
|---|---|
| Revenue Growth (YoY) | -3.80% |
| Gross Margin | +41.34% |
| Operating Margin | -103.55% |
| Profit Margin | -190.00% |
| ROE | -74.68% |
| Debt / Equity | 9.46 |
| Current Ratio | 2.02 |
| Total Cash | $1.94M |
| Total Debt | $2.56M |
| Free Cash Flow | $-8.83M |
Source: Nexqual, June 10, 2026 at 05:11 UTC.
Financial Health Score (KHRNF)
Nexqual rates KHRNF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:11 UTC.
| Growth | Strong — Revenue +60% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $2M cash vs $3M debt |
| Cash Flow | Weak — FCF negative: -$9M, burning cash |
| Efficiency | Critical — ROE -75%, ROA -20.8% |
Ownership (KHRNF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.21% |
| Shares Outstanding | 232.41M |
| Float | 204.94M |
Source: Nexqual, June 10, 2026 at 05:11 UTC.
Leadership (KHRNF)
KHRNF is led by Alvaro Francisco Torres (age 46), Co-Founder, CEO & Director, per Nexqual as of June 10, 2026 at 05:11 UTC.
| Co-Founder, CEO & Director | Alvaro Francisco Torres (age 46) |
|---|---|
| President of Khiron Europe | Franziska Katterbach |
| Chief Financial Officer | Michael John O'Connor MA (age 58) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ELLXF | Elixinol Wellness Ltd. | USD 0.01 | ▲ 102.44% |
| ITHUF | iAnthus Capital Holdings, Inc. | USD 0 | ▼ 8% |
| MEDIF | Medipharm Labs Corporation | USD 0.05 | ▼ 11.19% |
| GGBXF | GREEN GROWTH BRANDS INC | USD 0 | ▲ 0% |
| TGIFF | 1933 Industries Inc. | USD 0.01 | ▼ 10.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:11 UTC. This page is informational and not investment advice.